These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30642283)

  • 1. Identifying primary site of lung-limited Cancer of unknown primary based on relative gene expression orderings.
    Li M; Li H; Hong G; Tang Z; Liu G; Lin X; Lin M; Qi L; Guo Z
    BMC Cancer; 2019 Jan; 19(1):67. PubMed ID: 30642283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circumvent the uncertainty in the applications of transcriptional signatures to tumor tissues sampled from different tumor sites.
    Cheng J; Guo Y; Gao Q; Li H; Yan H; Li M; Cai H; Zheng W; Li X; Jiang W; Guo Z
    Oncotarget; 2017 May; 8(18):30265-30275. PubMed ID: 28427173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples.
    Chen R; Guan Q; Cheng J; He J; Liu H; Cai H; Hong G; Zhang J; Li N; Ao L; Guo Z
    Oncotarget; 2017 Jan; 8(4):6652-6662. PubMed ID: 28036264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative transcriptional signature to reclassify estrogen receptor status of breast cancer patients.
    Cai H; Guo W; Zhang S; Li N; Wang X; Liu H; Chen R; Wang S; Guo Z; Li J
    Breast Cancer Res Treat; 2018 Jul; 170(2):271-277. PubMed ID: 29572677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two novel qualitative transcriptional signatures robustly applicable to non-research-oriented colorectal cancer samples with low-quality RNA.
    Cheng J; Guo Y; Guan G; Huang H; Jiang F; He J; Wu J; Guo Z; Liu X; Ao L
    J Cell Mol Med; 2021 Apr; 25(7):3622-3633. PubMed ID: 33719152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A qualitative transcriptional signature to reclassify histological grade of ER-positive breast cancer patients.
    Li J; Jiang W; Liang Q; Liu G; Dai Y; Zheng H; Yang J; Cai H; Zheng G
    BMC Genomics; 2020 Apr; 21(1):283. PubMed ID: 32252627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A qualitative transcriptional signature for predicting the biochemical recurrence risk of prostate cancer patients after radical prostatectomy.
    Li X; Huang H; Zhang J; Jiang F; Guo Y; Shi Y; Guo Z; Ao L
    Prostate; 2020 Apr; 80(5):376-387. PubMed ID: 31961962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms.
    Guan Q; Chen R; Yan H; Cai H; Guo Y; Li M; Li X; Tong M; Ao L; Li H; Hong G; Guo Z
    Oncotarget; 2016 Oct; 7(42):68909-68920. PubMed ID: 27634898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistically controlled identification of differentially expressed genes in one-to-one cell line comparisons of the CMAP database for drug repositioning.
    He J; Yan H; Cai H; Li X; Guan Q; Zheng W; Chen R; Liu H; Song K; Guo Z; Wang X
    J Transl Med; 2017 Sep; 15(1):198. PubMed ID: 28962576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin.
    Ferracin M; Pedriali M; Veronese A; Zagatti B; Gafà R; Magri E; Lunardi M; Munerato G; Querzoli G; Maestri I; Ulazzi L; Nenci I; Croce CM; Lanza G; Querzoli P; Negrini M
    J Pathol; 2011 Sep; 225(1):43-53. PubMed ID: 21630269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer.
    Guan Q; Yan H; Chen Y; Zheng B; Cai H; He J; Song K; Guo Y; Ao L; Liu H; Zhao W; Wang X; Guo Z
    BMC Genomics; 2018 Jan; 19(1):99. PubMed ID: 29378509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A signature based on relative gene expression orderings for lung cancer diagnosis].
    Chen Y; Zheng B; Lin Y; Zhu H; Zheng Z; Guan Q; Guo Z; Yan H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2017 Feb; 34(1):129-33. PubMed ID: 29717600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy.
    Qi L; Li Y; Qin Y; Shi G; Li T; Wang J; Chen L; Gu Y; Zhao W; Guo Z
    Br J Cancer; 2016 Dec; 115(12):1513-1519. PubMed ID: 27855439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating hepatocellular carcinoma cell lines for tumour samples using within-sample relative expression orderings of genes.
    Ao L; Guo Y; Song X; Guan Q; Zheng W; Zhang J; Huang H; Zou Y; Guo Z; Wang X
    Liver Int; 2017 Nov; 37(11):1688-1696. PubMed ID: 28481424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An individualized gene expression signature for prediction of lung adenocarcinoma metastases.
    Qi L; Li T; Shi G; Wang J; Li X; Zhang S; Chen L; Qin Y; Gu Y; Zhao W; Guo Z
    Mol Oncol; 2017 Nov; 11(11):1630-1645. PubMed ID: 28922552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the site of origin of tumors by a gene expression signature derived from normal tissues.
    Staub E; Buhr HJ; Gröne J
    Oncogene; 2010 Aug; 29(31):4485-92. PubMed ID: 20514016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups.
    Li X; Cai H; Zheng W; Tong M; Li H; Ao L; Li J; Hong G; Li M; Guan Q; Yang S; Yang D; Lin X; Guo Z
    Oncotarget; 2016 Feb; 7(8):8743-55. PubMed ID: 26840027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative transcriptional signature for the histological reclassification of lung squamous cell carcinomas and adenocarcinomas.
    Li X; Shi G; Chu Q; Jiang W; Liu Y; Zhang S; Zhang Z; Wei Z; He F; Guo Z; Qi L
    BMC Genomics; 2019 Nov; 20(1):881. PubMed ID: 31752667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary.
    Varadhachary GR; Spector Y; Abbruzzese JL; Rosenwald S; Wang H; Aharonov R; Carlson HR; Cohen D; Karanth S; Macinskas J; Lenzi R; Chajut A; Edmonston TB; Raber MN
    Clin Cancer Res; 2011 Jun; 17(12):4063-70. PubMed ID: 21531815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An individualized prognostic signature and multi‑omics distinction for early stage hepatocellular carcinoma patients with surgical resection.
    Ao L; Song X; Li X; Tong M; Guo Y; Li J; Li H; Cai H; Li M; Guan Q; Yan H; Guo Z
    Oncotarget; 2016 Apr; 7(17):24097-110. PubMed ID: 27006471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.